Orthopedic Biomaterials Market Report Suite - United States - 2022-2028 - MedSuite

Orthopedic Biomaterials Market Report Suite - United States - 2022-2028 - MedSuite

Overall, the U.S. Orthopedic Biomaterials market was valued at $3.7 billion in 2021. This number is expected to increase at a CAGR of 3.6% to reach $4.7 billion over the forecasted period.

Demographic factors in the U.S. continue to be the largest driver within the orthopedic biomaterials market. This is mostly due to the growing elderly population, and the high frequency of obesity within the United States, both of which are correlated to the occurrence of osteoarthritis and other degenerative diseases.

In 2021, the largest segment of the total U.S. orthopedic biomaterials market was bone graft substitutes, whilst the second largest segment, hyaluronic viscosupplementation, followed closely behind. Segment growth for the bone graft substitute market has been consistent and is anticipated to remain following this trend, as bone graft substitutes have already proven in many cases to be very effective.

MARKET REPORT DATA TYPES INCLUDED

Unit Sales, Procedure Numbers, Average Selling Prices, Market Value & Growth Trends

10 Year Scope

Market Drivers & Limiters for Each Segment

Competitive Analysis with Market Shares for Each Segment

Recent Mergers & Acquisitions

Disease Overviews and Demographic Information

Company Profiles, Product Portfolios and SWOT for Top Competitors

COVID-19 IMPACT ON THE U.S. ORTHOPEDIC BIOMATERIALS MARKET

The impact of COVID-19 on the U.S. orthopedic biomaterials market was prominent, but the market is expected to return to pre-pandemic numbers within the next few years. As the pandemic continued, hospitals began shutting down elective surgeries since hospital beds, personal protective equipment (PPE) and hospital staff were devoted to treating COVID-19 patients in addition to urgent procedures. This meant that a large majority of orthopedic surgeries were postponed during 2020 going into 2021.

U.S. ORTHOPEDIC BIOMATERIALS MARKET SHARE INSIGHTS

Overall, within the U.S. orthopedic biomaterials market there are three leading competitors: Medtronic, DePuy Synthes, and Zimmer Biomet.

As of 2021, Medtronic has kept its top spot as the leader within the U.S. orthopedic biomaterials market, this is largely thanks to its growth factor product, INFUSE®. The company also maintained a strong presence within the bone graft substitute market, and it is expected to continue holding its top spot over the next few years.

MARKET SEGMENTATION SUMMARY

While this report suite contains all applicable market data, each of the markets are also available as stand alone MedCore reports. This allows you to get access to only the specific market segment research that you need. You can view all these included reports and segmentation here:

U.S. Orthopedic Biomaterials Procedure Numbers– MedPro – Includes procedure numbers for: Bone Graft Substitute, Growth Factor Bone Grafts, Cellular Allografts, Cell Therapy, Hyaluronic Acid (HA) Viscosupplementation, and Cartilage Repair.

U.S. Orthopedic Bone Graft Substitute Market – MedCore – The total market for bone graft substitutes includes allografts, demineralized bone matrices (DBM), xenografts and synthetic grafts.

U.S. Orthopedic Growth Factor Market– MedCore – This includes segments for cervical disc degeneration, tibial fracture, spine, and ankle and hindfoot fusion.

U.S. Orthopedic Cellular Allograft Market– MedCore – The orthopedic cellular allograft market is segmented into usage for the cervical and lumbar regions of the spine.

U.S. Orthopedic Cell Therapy Market– MedCore – The scope of the orthopedic cell therapy market in this report covers platelet-rich plasma (PRP) and concentrated bone marrow aspirate (BMAC).

U.S. Hyaluronic Acid Viscosupplementation Market – MedCore – Hyaluronic acid products involve one-, two-, three- or five-dose cycles, with the actual number of doses taken often being less than a full treatment.

U.S. Orthopedic Cartilage Repair Market– MedCore – The total orthopedic cartilage repair market has generally been increasing in value.

RESEARCH SCOPE SUMMARY

Regions – United States

Base Year – 2021

Forecast – 2022-2028

Historical Data – 2018-2021

Quantitative Coverage – Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.

Qualitative Coverage – COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.

Data Sources – Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.

WHY CHOOSE iDATA?

Experts Only – iData has been around for over 16 years and is the trusted source of intelligent, data-driven insights by key industry players. We are comprised of specialists with a sole focus on medical and dental devices. Our research and consulting focus never strays from the medical device industry and, because of this, we know the industry like the back of our hands.

Attention to Details - It’s our attention to the small stuff, scheduling of timelines and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.

Pricing - Our prices are competitive and fair. We strive for success and want our clients to as well, with the level of detail our reports achieve along with the extensive segmentation, no other reports compare at our price point.

Work with us, and you’ll work with seasoned professionals – vigilant of deadlines, and committed to providing the most up-to-date, accurate medical device market research.

The full report suite on the U.S. market for orthopedic biomaterials includes bone graft substitutes, which are represented by allografts, demineralized bone matrices (DBMs), xenografts and synthetic bone graft markets. The report also includes orthopedic growth factors, cellular allografts, orthopedic cell therapy, represented by bone marrow aspirate concentrate and platelet-rich plasma, hyaluronic acid (HA) viscosupplementation in single, two, three and five-injection cycles and, finally, orthopedic cartilage repair. Cartilage repair is represented by the osteochondral allograft, meniscal allograft, autologous chondrocyte implantation, particulated juvenile allograft and microfracture adjunct segments.